HIV/AIDS: Current Treatments, Life Expectancy, and Cure Research
There is no cure for HIV, but antiretroviral therapy (ART) transforms it into a manageable chronic condition.
Antiretroviral Therapy (ART)
- Mechanism: Combination of ≥3 drugs from ≥2 classes targeting different steps of HIV lifecycle.
- Classes: NRTIs, NNRTIs, PIs, INSTIs (preferred first-line), entry inhibitors, capsid inhibitors.
- Goal: Viral suppression (<50 copies/mL) → immune recovery (CD4↑), prevents transmission (U=U), normal lifespan.
- First-line examples: Bictegravir/tenofovir alafenamide/emtricitabine (Biktarvy), dolutegravir/lamivudine (Dovato), dolutegravir + TDF/FTC.
Outcomes with Modern ART
- Life expectancy near normal if diagnosed early and adherent.
- CD4 recovery reduces opportunistic infection risk.
- Undetectable = Untransmittable (U=U): zero sexual transmission risk.
Challenges
- Lifelong adherence required.
- Drug resistance if adherence poor.
- Long-term toxicities (renal, bone, metabolic, cardiovascular).
- Stigma, access disparities, cost.
Cure Research
- "Berlin Patient" & "London Patient": CCR5Δ32 stem cell transplant – not scalable.
- Strategies: "Shock and kill" (latency reversal), gene editing (CRISPR), broadly neutralizing antibodies, therapeutic vaccines, immune modulators.
- Status: Experimental; no widely applicable cure yet.
Key Message
Test early, treat immediately, stay adherent. With ART, people with HIV live long, healthy lives and cannot transmit the virus sexually.
HIV & AIDS - Related Articles
- How HIV Is Transmitted: A Clear Guide
- Understanding HIV Therapy Side Effects: What to Expect
- Early HIV Symptoms: Acute, Chronic & Advanced Stage Signs
- HIV Risk from Shared Drinks with an Open Cut: Evidence-Based Assessment
- HIV and AIDS: Transmission, Pathogenesis, Treatment, and Prevention
- HIV vs. Common Cold: A Detailed Comparison
- Burning Urination: Common Causes—Not Typically HIV/AIDS
